Pathogenesis and treatment options for hemophilic synovitis
File(s)Haemophillic synovitis review to deposit.pdf (704.77 KB)
Accepted version
Author(s)
Carlos Rodriguez-Merchan, E
Liddle, Alexander D
Type
Journal Article
Abstract
Introduction: Hemophilia is characterized by recurrent bleeding episodes, most commonly in the knees, elbows and ankles. Repeated hemarthroses lead to synovial hypertrophy and a vicious cycle of chronic synovitis arises, leading to destruction of the joint.
Areas covered: This article covers the pathogenesis of chronic hemophilic synovitis and its treatment by means of different types of synovectomy.
Expert opinion: Both radiosynovectomy (RS) and arthroscopic synovectomy considerably improve the frequency of bleeding episodes. RS is the best option for patients with synovitis unresponsive to a three-month trial of hematological prophylaxis. If the bleeding is refractory to three successive episodes of RS at six monthly intervals, arthroscopic synovectomy is indicated. Open synovectomy should be reserved for adults with elbow synovitis requiring radial head removal and synovectomy in the same surgical session. RS is effective and safe, and particularly helpful in patients with inhibitors as they are at greatest risk of bleeding episodes and have the highest risk of complications of surgery.
Areas covered: This article covers the pathogenesis of chronic hemophilic synovitis and its treatment by means of different types of synovectomy.
Expert opinion: Both radiosynovectomy (RS) and arthroscopic synovectomy considerably improve the frequency of bleeding episodes. RS is the best option for patients with synovitis unresponsive to a three-month trial of hematological prophylaxis. If the bleeding is refractory to three successive episodes of RS at six monthly intervals, arthroscopic synovectomy is indicated. Open synovectomy should be reserved for adults with elbow synovitis requiring radial head removal and synovectomy in the same surgical session. RS is effective and safe, and particularly helpful in patients with inhibitors as they are at greatest risk of bleeding episodes and have the highest risk of complications of surgery.
Date Issued
2017-01-12
Date Acceptance
2017-01-03
Citation
Expert opinion on orphan drugs, 2017, 5 (2), pp.173-179
ISSN
2167-8707
Publisher
Taylor & Francis
Start Page
173
End Page
179
Journal / Book Title
Expert opinion on orphan drugs
Volume
5
Issue
2
Copyright Statement
© 2017 Taylor & Francis. This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Orphan Drugs on 12 Jan 2017, available online: https://doi.org/10.1080/21678707.2017.1279050.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394437600008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Hemophilia
synovitis
pathogenesis
treatment
radiosynovectomy
arthroscopic synovectomy
INDUCED JOINT DAMAGE
P-32 CHROMIC PHOSPHATE
ARTHROSCOPIC SYNOVECTOMY
RADIONUCLIDE SYNOVECTOMY
SHORT-TERM
FOLLOW-UP
RADIOSYNOVECTOMY
ARTHROPATHY
SYNOVIORTHESIS
RADIOSYNOVIORTHESIS
Publication Status
Published
Date Publish Online
2017-01-11